HEADER PROTEIN BINDING 25-JUN-21 7R7Q TITLE IMMATURE HIV-1 CACTD-SP1 LATTICE WITH INOSITOL HEXAKISPHOSPHATE (IP6) COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG POLYPROTEIN; COMPND 3 CHAIN: G, H, I, J, K, L; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: GAG; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS HIV-1 CAPSID, MATURATION INHIBITORS, HIV-AIDS, PROTEIN BINDING EXPDTA SOLID-STATE NMR NUMMDL 5 AUTHOR S.SARKAR,K.K.ZADROZNY,R.ZADOROZHNYI,R.W.RUSSELL,C.M.QUINN, AUTHOR 2 A.KLEINPETER,S.ABLAN,H.MESHKIN,J.R.PERILLA,B.K.GANSER-PORNILLOS, AUTHOR 3 O.PORNILLOS,E.O.FREED,A.M.GRONENBORN,T.POLENOVA REVDAT 3 15-MAY-24 7R7Q 1 REMARK REVDAT 2 22-MAR-23 7R7Q 1 JRNL REVDAT 1 15-FEB-23 7R7Q 0 JRNL AUTH S.SARKAR,K.K.ZADROZNY,R.ZADOROZHNYI,R.W.RUSSELL,C.M.QUINN, JRNL AUTH 2 A.KLEINPETER,S.ABLAN,H.MESHKIN,J.R.PERILLA,E.O.FREED, JRNL AUTH 3 B.K.GANSER-PORNILLOS,O.PORNILLOS,A.M.GRONENBORN,T.POLENOVA JRNL TITL STRUCTURAL BASIS OF HIV-1 MATURATION INHIBITOR BINDING AND JRNL TITL 2 ACTIVITY. JRNL REF NAT COMMUN V. 14 1237 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36871077 JRNL DOI 10.1038/S41467-023-36569-Y REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 2.53 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7R7Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1000256134. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 277.15; 263.15; 194.15; 277.15; REMARK 210 268.15; 277.15 REMARK 210 PH : 8; 8; 8; 8; 8; 8 REMARK 210 IONIC STRENGTH : 250; 250; 250; 250; 250; 250 REMARK 210 PRESSURE : 1 ATM; 1 ATM; 1 ATM; 1 ATM; 1 REMARK 210 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 400 UM [U-100% 13C; U-100% 15N] REMARK 210 HIV-1 CACTD-SP1, 400 UM IP6, REMARK 210 PROTEIN BUFFER; 400 UM [U-100% REMARK 210 13C; U-100% 15N; 99.9%-2H] HIV-1 REMARK 210 CACTD-SP1, 400 UM IP6, PROTEIN REMARK 210 BUFFER; 400 UM [U-100% 13C; U- REMARK 210 100% 15N; 99.9%-2H] HIV-1 CACTD- REMARK 210 SP1, 400 UM IP6 S2, PROTEIN REMARK 210 BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D CORD 50 MS; 2D CORD 100 MS; REMARK 210 2D NCACX 50 MS; 3D NCOCX 25 MS; REMARK 210 2D CORD 25 MS; 2D NCACX 25 MS; REMARK 210 2D NCOCX 25 MS; 3D NCACX 25 MS; REMARK 210 2D HC CP HETCOR; 2D DOUBLEREDOR REMARK 210 HETCOR; 1D 31P DIRECT REMARK 210 POLARIZATION; 1D 31P CROSS REMARK 210 POLARIZATION; 1D DOUBLEREDOR; 2D REMARK 210 HNH HETCOR REMARK 210 SPECTROMETER FIELD STRENGTH : 850 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, NMRFAM-SPARKY REMARK 210 3.115, CCPNMR ANALYSIS 2.4, REMARK 210 TALOS-N, X-PLOR NIH 2.53 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 5 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: MAGIC ANGLE SPINNING REMARK 217 REMARK 217 SOLID STATE NMR STUDY REMARK 217 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLID REMARK 217 STATE NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 217 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 217 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O CYS I 198 H LEU I 202 1.56 REMARK 500 O ASP J 163 H ARG J 167 1.59 REMARK 500 O ASP K 166 H LYS K 170 1.59 REMARK 500 H GLN I 155 O ASN I 193 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR G 148 -15.31 76.23 REMARK 500 1 GLU G 187 -61.89 -91.78 REMARK 500 1 ALA G 194 48.16 -100.17 REMARK 500 1 ASN G 195 102.62 61.38 REMARK 500 1 PRO G 196 -34.16 -31.71 REMARK 500 1 ILE H 153 104.30 -35.45 REMARK 500 1 GLU H 187 -67.85 -90.64 REMARK 500 1 ALA H 194 43.90 -88.24 REMARK 500 1 ASN H 195 102.07 59.86 REMARK 500 1 PRO H 196 -40.02 -27.59 REMARK 500 1 THR I 148 -34.29 81.31 REMARK 500 1 ASP I 152 32.45 -97.32 REMARK 500 1 ALA I 194 30.80 -94.37 REMARK 500 1 ASN I 195 104.59 69.37 REMARK 500 1 PRO I 196 -22.45 -37.17 REMARK 500 1 PRO I 207 159.28 -49.58 REMARK 500 1 VAL I 221 106.28 -51.52 REMARK 500 1 PRO I 224 -18.27 -46.14 REMARK 500 1 THR J 148 20.48 84.09 REMARK 500 1 ASN J 193 34.12 -83.70 REMARK 500 1 ALA J 194 59.83 -111.18 REMARK 500 1 ASN J 195 99.15 52.87 REMARK 500 1 PRO J 196 -29.23 -32.25 REMARK 500 1 PRO J 207 152.31 -48.11 REMARK 500 1 THR K 148 -38.80 81.18 REMARK 500 1 ALA K 194 78.79 -101.89 REMARK 500 1 ASN K 195 98.59 49.75 REMARK 500 1 PRO K 196 -27.27 -33.48 REMARK 500 1 THR L 148 -11.26 75.62 REMARK 500 1 SER L 178 170.64 -49.42 REMARK 500 1 ALA L 194 44.92 -79.92 REMARK 500 1 ASN L 195 108.89 70.08 REMARK 500 1 PRO L 196 -28.16 -36.78 REMARK 500 2 ALA G 194 43.73 -109.45 REMARK 500 2 ASN G 195 105.54 64.42 REMARK 500 2 PRO G 196 -23.84 -36.29 REMARK 500 2 ILE H 153 123.24 -35.63 REMARK 500 2 ASP H 163 -60.01 -92.62 REMARK 500 2 GLU H 187 -61.48 -92.55 REMARK 500 2 ALA H 194 44.89 -75.57 REMARK 500 2 ASN H 195 99.87 59.19 REMARK 500 2 PRO H 196 -28.93 -29.70 REMARK 500 2 GLN I 176 70.80 -68.96 REMARK 500 2 ASN I 195 112.56 70.37 REMARK 500 2 PRO I 196 -13.34 -38.13 REMARK 500 2 PRO I 207 172.00 -38.85 REMARK 500 2 SER J 146 171.23 -47.79 REMARK 500 2 PRO J 147 119.50 -38.31 REMARK 500 2 THR J 148 95.23 50.98 REMARK 500 2 SER J 178 170.09 -58.13 REMARK 500 REMARK 500 THIS ENTRY HAS 167 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30930 RELATED DB: BMRB REMARK 900 IMMATURE HIV-1 CACTD-SP1 LATTICE WITH INOSITOL HEXAKISPHOSPHATE REMARK 900 (IP6) DBREF 7R7Q G 146 245 UNP Q72497 Q72497_9HIV1 278 377 DBREF 7R7Q H 146 245 UNP Q72497 Q72497_9HIV1 278 377 DBREF 7R7Q I 146 245 UNP Q72497 Q72497_9HIV1 278 377 DBREF 7R7Q J 146 245 UNP Q72497 Q72497_9HIV1 278 377 DBREF 7R7Q K 146 245 UNP Q72497 Q72497_9HIV1 278 377 DBREF 7R7Q L 146 245 UNP Q72497 Q72497_9HIV1 278 377 SEQADV 7R7Q GLY G 144 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q GLY G 145 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q THR G 241 UNP Q72497 PRO 373 ENGINEERED MUTATION SEQADV 7R7Q GLY H 144 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q GLY H 145 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q THR H 241 UNP Q72497 PRO 373 ENGINEERED MUTATION SEQADV 7R7Q GLY I 144 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q GLY I 145 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q THR I 241 UNP Q72497 PRO 373 ENGINEERED MUTATION SEQADV 7R7Q GLY J 144 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q GLY J 145 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q THR J 241 UNP Q72497 PRO 373 ENGINEERED MUTATION SEQADV 7R7Q GLY K 144 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q GLY K 145 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q THR K 241 UNP Q72497 PRO 373 ENGINEERED MUTATION SEQADV 7R7Q GLY L 144 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q GLY L 145 UNP Q72497 EXPRESSION TAG SEQADV 7R7Q THR L 241 UNP Q72497 PRO 373 ENGINEERED MUTATION SEQRES 1 G 102 GLY GLY SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 G 102 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 G 102 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 G 102 ASN TRP MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 G 102 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 G 102 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 G 102 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 G 102 MET SER GLN VAL THR ASN THR ALA THR ILE MET SEQRES 1 H 102 GLY GLY SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 H 102 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 H 102 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 H 102 ASN TRP MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 H 102 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 H 102 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 H 102 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 H 102 MET SER GLN VAL THR ASN THR ALA THR ILE MET SEQRES 1 I 102 GLY GLY SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 I 102 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 I 102 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 I 102 ASN TRP MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 I 102 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 I 102 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 I 102 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 I 102 MET SER GLN VAL THR ASN THR ALA THR ILE MET SEQRES 1 J 102 GLY GLY SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 J 102 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 J 102 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 J 102 ASN TRP MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 J 102 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 J 102 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 J 102 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 J 102 MET SER GLN VAL THR ASN THR ALA THR ILE MET SEQRES 1 K 102 GLY GLY SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 K 102 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 K 102 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 K 102 ASN TRP MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 K 102 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 K 102 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 K 102 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 K 102 MET SER GLN VAL THR ASN THR ALA THR ILE MET SEQRES 1 L 102 GLY GLY SER PRO THR SER ILE LEU ASP ILE ARG GLN GLY SEQRES 2 L 102 PRO LYS GLU PRO PHE ARG ASP TYR VAL ASP ARG PHE TYR SEQRES 3 L 102 LYS THR LEU ARG ALA GLU GLN ALA SER GLN GLU VAL LYS SEQRES 4 L 102 ASN TRP MET THR GLU THR LEU LEU VAL GLN ASN ALA ASN SEQRES 5 L 102 PRO ASP CYS LYS THR ILE LEU LYS ALA LEU GLY PRO GLY SEQRES 6 L 102 ALA THR LEU GLU GLU MET MET THR ALA CYS GLN GLY VAL SEQRES 7 L 102 GLY GLY PRO GLY HIS LYS ALA ARG VAL LEU ALA GLU ALA SEQRES 8 L 102 MET SER GLN VAL THR ASN THR ALA THR ILE MET HET IHP G 301 42 HETNAM IHP INOSITOL HEXAKISPHOSPHATE HETSYN IHP MYO-INOSITOL HEXAKISPHOSPHATE; INOSITOL 1,2,3,4,5,6- HETSYN 2 IHP HEXAKISPHOSPHATE FORMUL 7 IHP C6 H18 O24 P6 HELIX 1 AA1 PRO G 160 GLU G 175 1 16 HELIX 2 AA2 SER G 178 ASN G 193 1 16 HELIX 3 AA3 ASN G 195 GLY G 206 1 12 HELIX 4 AA4 THR G 210 GLY G 220 1 11 HELIX 5 AA5 GLY G 223 ASN G 240 1 18 HELIX 6 AA6 PRO H 160 GLU H 175 1 16 HELIX 7 AA7 SER H 178 ASN H 193 1 16 HELIX 8 AA8 ASN H 195 GLY H 206 1 12 HELIX 9 AA9 THR H 210 GLY H 220 1 11 HELIX 10 AB1 HIS H 226 VAL H 238 1 13 HELIX 11 AB2 SER I 149 ILE I 153 5 5 HELIX 12 AB3 PRO I 160 GLU I 175 1 16 HELIX 13 AB4 SER I 178 ASN I 193 1 16 HELIX 14 AB5 ALA I 194 GLY I 206 1 13 HELIX 15 AB6 THR I 210 GLY I 220 1 11 HELIX 16 AB7 GLY I 223 ASN I 240 1 18 HELIX 17 AB8 PRO J 160 GLU J 175 1 16 HELIX 18 AB9 SER J 178 ASN J 193 1 16 HELIX 19 AC1 ASN J 195 LEU J 205 1 11 HELIX 20 AC2 THR J 210 VAL J 221 1 12 HELIX 21 AC3 GLY J 223 ASN J 240 1 18 HELIX 22 AC4 SER K 149 ILE K 153 5 5 HELIX 23 AC5 PRO K 160 GLU K 175 1 16 HELIX 24 AC6 SER K 178 ASN K 193 1 16 HELIX 25 AC7 ASN K 195 LEU K 205 1 11 HELIX 26 AC8 THR K 210 GLN K 219 1 10 HELIX 27 AC9 GLY K 223 THR K 241 1 19 HELIX 28 AD1 PRO L 160 GLU L 175 1 16 HELIX 29 AD2 SER L 178 ASN L 193 1 16 HELIX 30 AD3 ALA L 194 LEU L 205 1 12 HELIX 31 AD4 THR L 210 GLN L 219 1 10 HELIX 32 AD5 GLY L 223 ASN L 240 1 18 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1